2786 Circulation December 24/31, 2013 platelet adhesiveness, persistently high platelet
counts, and decreased or impaired fibrinolysis. 20–22 Adding to the withdrawal of protection …

Importance Percutaneous coronary intervention (PCI) with stents is currently the most
commonly performed coronary revascularization procedure; hence, optimizing post-PCI …

Importance The current recommendation is for at least 12 months of dual antiplatelet therapy
after implantation of a drug-eluting stent. However, the optimal duration of dual antiplatelet …

Importance Guidelines recommend delaying noncardiac surgery in patients after coronary
stent procedures for 1 year after drug-eluting stents (DES) and for 6 weeks after bare metal …

BACKGROUND: Stent thrombosis remains among the most feared complications of
percutaneous coronary intervention (PCI) with stenting. However, data on its incidence and …

Background It is unclear how to appropriately manage discontinuation and resumption of
antiplatelet therapy in patients with coronary stents who need noncardiac surgery. We …

Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior
descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non …

Coronary artery disease is the leading cause of death worldwide and it often clinically
manifests as stable angina. The optimal diagnostic and therapeutic strategy of patients with …

It is known that the hospital readmissions for non-cardiac surgery and for bleedings after
myocardial infarction (MI) were common and negatively influenced mortality [1–3]. On the …

Outcome data regarding postoperative acute coronary syndrome treated with percutaneous
coronary intervention (PCI) are limited. The objective of this study was to determine clinical …